HR NEWS

Arthritis drug may be new hope for skin cancer

Arthritis drug may be new hope for skin cancer

Combining the treatment for the most deadly form of skin cancer with a common anti-rheumatic drug could provide more effective results, new research has shown. The findings showed that using “leflunomide” — an immunosuppressive drug approved for treatment of rheumatoid arthritis — in combination with another melanoma drug, selumetinib almost completely stopped the growth of a melanoma tumour in mice. “By combining therapies, it’s possible to attack the disease from several angles, which makes it harder for the melanoma to develop resistance to any of the drugs,” said Grant Wheeler from the University of East Anglia (UEA) in the UK. “Our research has shown that there could also be further benefits – by joining these two drugs together you may be able to enhance their effects, getting a treatment that is more than the sum of its parts,” Wheeler said.

Although only five per cent of skin cancer cases involve melanoma, it causes the majority of deaths from the disease. If caught early, melanoma is very treatable, but once the cancer has metastasised or spread, then treatment becomes more difficult. The research, published in the journal Oncotarget, tested leflunomide’s effect against melanoma with selumetinib. When the team tested leflunomide in the lab, it was found to work on melanoma cells irrespective of the genetic signature of the cancer. This means that leflunomide has the potential to be used in all melanoma cases, not just for tumours harbouring BRAF mutations, the researchers said.

However, when leflunomide was tested on melanoma cells jointly with selumetinib, the scientists found it was more effective than either drug on its own. In mice, the two drugs together almost completely halted the growth of the tumour over a 12 day period, which far outstripped the effect of either drug used in isolation, the researchers said.

6 months ago

By HR Reporters

Related Tags :   • Health News

Social Share : Share      

Comments.....

Submit new comment

Most Viewed

Air India unauthorised payment scam: Chief Vigilance Officer Shobha Ohatker unde...

10 months ago

Uber hires legal chief Tony West from Pepsi amid mounting pressure...

8 months ago

Prosecutors appeal against ruling on Samsung heir...

10 months ago

Railways can create 1 million jobs; global tender soon for tracks...

8 months ago

Snapdeal CFO Anup Vikal quits; acquisition talks with Flipkart collapse...

8 months ago

Ketamine may reduce suicidal thoughts, says study...

6 months ago

Carfilzomib may up risk of cardiovascular problems: Study...

5 months ago

This company spent $6m to close gender pay gap...

8 months ago

Arundhati Bhattacharya – Captain Courageous: SBI chairman weathered NPA storm an...

8 months ago

FE Best Bank Awards - 2017 Declared...

6 months ago

Most Shared

Mass redundancies for Quebec cookie factory...

2 years ago

Trump this: 5 bold predictions for how he’ll impact HR...

2 years ago

InfoTycoon appoints existing President and COO Kevin George to succeed James Dav...

2 years ago

Sushant Dwivedy joins Aspiring Minds as SVP-Enterprise Client Solutions...

2 years ago

Uber introduces special reward programme...

2 years ago

Standard Chartered Bank to reduce 10% corporate & institutional banking staff...

2 years ago

National CineMedia (NCM) creates Affiliate Partnerships team, names Stacie Tursi...

2 years ago

OCC Names New CFO, Treasurer, and Chief Compliance Officer...

2 years ago

Beards at work are now a major turn-off say 61% of female office workers...

2 years ago

First female fast jet pilot of Britain hired as director at PwC...

2 years ago